期刊
CLINICAL IMMUNOLOGY
卷 160, 期 2, 页码 349-357出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2015.05.012
关键词
Aspirin-intolerant asthma; Desensitization; Quality of life; Interleukin-10; Interferon-gamma
类别
资金
- Tehran University of Medical Sciences [92-01-119-20728]
The effect of aspirin desensitization (AD) on immunologic profile of patients with AERD has been poorly understood. This study is aimed at investigating the effect of AD on clinical and immunological markers of patients with AERD. This randomized double-blind placebo-controlled trial comprised 34 adult patients (67.6% female) with chronic rhinosinusitis, nasal polyps, and aspirin-intolerant asthma. The active group underwent AD over a 2-day period with increasing doses of aspirin (60, 125, 325, and 625 mg), followed by receiving aspirin 625 mg twice daily for 6 months. Symptom scores and medication needs of patients with AERD who have undergone AD were significantly lower compared to the placebo group after 6 months (7.5 +/- 3.5 vs. 10.6 +/- 3.8 and 9.3 +/- 2.0 vs. 11.0 +/- 3.1, respectively, all p < 0.05). However, no significant difference was observed in serum concentration of IL-10, IFN-gamma, and TGF-beta between two groups neither at baseline nor at the end of study. (C) 2015 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据